Published in Science on February 28, 2013
Regulation of type I interferon responses. Nat Rev Immunol (2014) 3.60
A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet (2016) 3.16
Type I interferons in infectious disease. Nat Rev Immunol (2015) 2.37
The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. Cell Host Microbe (2015) 2.26
T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol (2015) 2.24
Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science (2014) 2.22
Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis. Cell Host Microbe (2015) 2.15
Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis. J Invest Dermatol (2014) 1.56
Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol (2014) 1.40
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One (2013) 1.31
Deletion of the cyclic di-AMP phosphodiesterase gene (cnpB) in Mycobacterium tuberculosis leads to reduced virulence in a mouse model of infection. Mol Microbiol (2014) 1.22
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur J Immunol (2014) 1.15
Guarding the frontiers: the biology of type III interferons. Nat Immunol (2015) 1.12
The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci (2014) 1.12
The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos Trans R Soc Lond B Biol Sci (2014) 1.06
Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions. J Clin Immunol (2013) 1.02
Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe (2015) 1.01
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes. Mol Cancer Res (2014) 0.99
Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides. Front Microbiol (2013) 0.98
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection. Front Cell Infect Microbiol (2013) 0.96
Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity. J Clin Invest (2014) 0.96
IL-32 is a molecular marker of a host defense network in human tuberculosis. Sci Transl Med (2014) 0.95
Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal (2013) 0.95
Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways. PLoS Pathog (2013) 0.94
Biomarkers Can Identify Pulmonary Tuberculosis in HIV-infected Drug Users Months Prior to Clinical Diagnosis. EBioMedicine (2014) 0.93
Confounding roles for type I interferons during bacterial and viral pathogenesis. Int Immunol (2013) 0.93
Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal. BMC Infect Dis (2015) 0.93
The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev (2015) 0.92
Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae. PLoS Negl Trop Dis (2014) 0.92
PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic. PLoS Negl Trop Dis (2014) 0.92
T-cell regulation in lepromatous leprosy. PLoS Negl Trop Dis (2014) 0.91
Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity. Front Immunol (2014) 0.91
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res (2015) 0.90
The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol Rev (2014) 0.89
Bettering BCG: a tough task for a TB vaccine? Nat Med (2013) 0.89
Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol (2014) 0.88
Comparative transcriptomics of Atlantic Salmo salar, chum Oncorhynchus keta and pink salmon O. gorbuscha during infections with salmon lice Lepeophtheirus salmonis. BMC Genomics (2014) 0.88
Gene expression profiling specifies chemokine, mitochondrial and lipid metabolism signatures in leprosy. PLoS One (2013) 0.87
Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design. Front Immunol (2014) 0.87
The Mechanism for Type I Interferon Induction by Mycobacterium tuberculosis is Bacterial Strain-Dependent. PLoS Pathog (2016) 0.86
Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev (2015) 0.86
Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol (2013) 0.84
Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections. Genes Immun (2014) 0.83
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Front Immunol (2017) 0.83
The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics (2014) 0.82
microRNAs in mycobacterial disease: friend or foe? Front Genet (2014) 0.81
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes. Cell (2016) 0.81
Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis. Infect Immun (2014) 0.81
Autophagy in tuberculosis. Cold Spring Harb Perspect Med (2014) 0.81
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections. MBio (2016) 0.81
The Inflammatory Transcription Factors NFκB, STAT1 and STAT3 Drive Age-Associated Transcriptional Changes in the Human Kidney. PLoS Genet (2015) 0.80
High-throughput screening normalized to biological response: application to antiviral drug discovery. J Biomol Screen (2013) 0.80
IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy. PLoS Negl Trop Dis (2014) 0.80
Scaling of immune responses against intracellular bacterial infection. EMBO J (2014) 0.80
Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection. Liver Int (2015) 0.80
Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling. J Immunol (2016) 0.80
Transcriptional changes that characterize the immune reactions of leprosy. J Infect Dis (2014) 0.79
S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages. PLoS Pathog (2016) 0.79
Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection. Mucosal Immunol (2015) 0.79
Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults. Tuberculosis (Edinb) (2016) 0.79
The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection. Tuberculosis (Edinb) (2015) 0.79
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia. Front Immunol (2016) 0.79
Mincle-mediated translational regulation is required for strong nitric oxide production and inflammation resolution. Nat Commun (2016) 0.78
Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs. PLoS One (2015) 0.78
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial. EBioMedicine (2016) 0.78
A compendium of monocyte transcriptome datasets to foster biomedical knowledge discovery. F1000Res (2016) 0.78
Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease. Mucosal Immunol (2016) 0.78
Fine-tuning of macrophage activation using synthetic rocaglate derivatives. Sci Rep (2016) 0.78
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Mol Ther Methods Clin Dev (2016) 0.77
In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis. PLoS Pathog (2016) 0.77
Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment. PLoS One (2015) 0.77
IL-27 Suppresses Antimicrobial Activity in Human Leprosy. J Invest Dermatol (2015) 0.77
A curated compendium of monocyte transcriptome datasets of relevance to human monocyte immunobiology research. F1000Res (2016) 0.77
Mast cells fuel the fire of malaria immunopathology. Nat Med (2013) 0.76
Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways. Am J Neurodegener Dis (2015) 0.76
Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice. Eur J Immunol (2016) 0.76
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection. Cell Rep (2016) 0.76
AIM2 inhibits autophagy and IFN-β production during M. bovis infection. Oncotarget (2016) 0.76
Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype. PLoS Pathog (2017) 0.75
Taking sides: interferons in leprosy. Cell Host Microbe (2013) 0.75
Evolutionary Origin of the Interferon-Immune Metabolic Axis: The Sterol-Vitamin D Link. Front Immunol (2017) 0.75
Type I Interferon is Pathogenic During Chronic Mycobacterium africanum Infection. J Infect Dis (2016) 0.75
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight (2016) 0.75
Interferon Lambda: Modulating Immunity in Infectious Diseases. Front Immunol (2017) 0.75
Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection. J Exp Med (2017) 0.75
Mycobacterium leprae Activates Toll-Like Receptor-4 Signaling and Expression on Macrophages Depending on Previous Bacillus Calmette-Guerin Vaccination. Front Cell Infect Microbiol (2016) 0.75
Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection. Biomed Res Int (2015) 0.75
The involvement of endothelial mediators in leprosy. Mem Inst Oswaldo Cruz (2016) 0.75
The impact of ISGylation during Mycobacterium tuberculosis infection in mice. Microbes Infect (2017) 0.75
Jagged1 Instructs Macrophage Differentiation in Leprosy. PLoS Pathog (2016) 0.75
IL-21 Receptor Signaling Is Essential for Optimal CD4(+) T Cell Function and Control of Mycobacterium tuberculosis Infection in Mice. J Immunol (2017) 0.75
Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense. PLoS Pathog (2017) 0.75
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 10.37
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med (2004) 4.34
Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity (2011) 3.97
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol (2010) 3.25
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med (2010) 2.66
Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med (1985) 2.57
Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A (2012) 2.42
INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res (2008) 2.31
Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One (2009) 2.14
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol (2008) 1.79
Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One (2010) 1.73
Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J Immunol (2011) 1.58
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55
Association of vitamin D receptor genotype with leprosy type. J Infect Dis (1999) 1.44
MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med (2012) 1.43
T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A (2010) 1.42
Molecular determination of Mycobacterium leprae viability by use of real-time PCR. J Clin Microbiol (2009) 1.37
Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J Immunol (2010) 1.31
Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy. Int J Lepr (1949) 0.86
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A (2007) 11.42
An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature (2007) 10.92
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature (2011) 10.77
Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet (2008) 10.72
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A (2010) 8.56
Dissecting biological "dark matter" with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Natl Acad Sci U S A (2007) 7.82
Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A (2006) 7.77
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol (2011) 7.53
IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity (2002) 6.85
Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A (2003) 6.49
Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell (2003) 6.38
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A (2008) 5.59
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature (2005) 5.56
Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol (2002) 5.48
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science (2013) 5.10
Microbiology in the post-genomic era. Nat Rev Microbiol (2008) 4.88
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61
Ipr1 gene mediates innate immunity to tuberculosis. Nature (2005) 4.53
Update in vitamin D. J Clin Endocrinol Metab (2010) 4.48
Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol (2007) 4.44
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell (2011) 4.43
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci U S A (2005) 4.43
Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med (2004) 4.34
MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity (2006) 4.28
LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell (2004) 4.20
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14
Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science (2013) 4.14
Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol (2008) 3.91
DUBA: a deubiquitinase that regulates type I interferon production. Science (2007) 3.88
Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci U S A (2002) 3.85
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest (2007) 3.82
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature (2011) 3.63
Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest (2010) 3.40
Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J (2010) 3.39
Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol (2013) 3.32
Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet (2003) 3.30
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol (2004) 3.27
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med (2003) 3.24
Assembly of the human intestinal microbiota. Trends Ecol Evol (2006) 3.21
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J (2006) 3.13
Susceptibility to leprosy is associated with PARK2 and PACRG. Nature (2004) 3.07
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity (2011) 3.01
Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell (2003) 2.99
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest (2009) 2.96
Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis (2007) 2.89
Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res (2012) 2.81
Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med (2004) 2.80
Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun (2007) 2.80
Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet (2009) 2.76
Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res (2006) 2.75
Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease. Appl Environ Microbiol (2003) 2.72
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci U S A (2004) 2.68
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest (2008) 2.66
The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev (2003) 2.66
Microbial threat lists: obstacles in the quest for biosecurity? Nat Rev Microbiol (2010) 2.63
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med (2005) 2.62
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature (2002) 2.60
Public health and biosecurity. Adaptations of avian flu virus are a cause for concern. Science (2012) 2.52
Toll-like receptors induce a phagocytic gene program through p38. J Exp Med (2003) 2.49
Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity (2012) 2.47
Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time. Genome Res (2010) 2.46
Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol (2009) 2.45